Compile Data Set for Download or QSAR
Report error Found 111 Enz. Inhib. hit(s) with all data for entry = 10684
TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559715(WO2022109117, Example 60)
Affinity DataIC50: 0.0400nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559716(WO2022109117, Example 61)
Affinity DataIC50: 0.0500nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559737(WO2022109117, Example 82)
Affinity DataIC50: 0.0700nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559656(WO2022109117, Example 1)
Affinity DataIC50: 0.0900nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559734(WO2022109117, Example 79)
Affinity DataIC50: 0.100nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559670(WO2022109117, Example 17 | WO2022109117, Example 1...)
Affinity DataIC50: 0.100nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559675(WO2022109117, Example 20)
Affinity DataIC50: 0.100nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559657(WO2022109117, Example 2)
Affinity DataIC50: 0.110nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559745(WO2022109117, Example 90)
Affinity DataIC50: 0.110nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559711(WO2022109117, Example 56)
Affinity DataIC50: 0.110nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559747(WO2022109117, Example 92)
Affinity DataIC50: 0.130nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559712(WO2022109117, Example 57)
Affinity DataIC50: 0.130nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559673(WO2022109117, Example 18)
Affinity DataIC50: 0.140nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559658(WO2022109117, Example 3)
Affinity DataIC50: 0.140nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559725(WO2022109117, Example 70)
Affinity DataIC50: 0.140nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559759(WO2022109117, Example 104)
Affinity DataIC50: 0.140nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559760(WO2022109117, Example 105)
Affinity DataIC50: 0.140nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559736(WO2022109117, Example 81)
Affinity DataIC50: 0.160nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559697(WO2022109117, Example 42)
Affinity DataIC50: 0.170nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559669(WO2022109117, Example 14)
Affinity DataIC50: 0.180nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559670(WO2022109117, Example 17 | WO2022109117, Example 1...)
Affinity DataIC50: 0.180nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559668(WO2022109117, Example 13)
Affinity DataIC50: 0.200nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559726(WO2022109117, Example 71)
Affinity DataIC50: 0.210nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559758(WO2022109117, Example 103)
Affinity DataIC50: 0.210nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559722(WO2022109117, Example 67)
Affinity DataIC50: 0.220nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559735(WO2022109117, Example 80)
Affinity DataIC50: 0.230nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559677(WO2022109117, Example 22)
Affinity DataIC50: 0.230nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559729(WO2022109117, Example 74)
Affinity DataIC50: 0.240nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559702(WO2022109117, Example 47)
Affinity DataIC50: 0.25nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559721(WO2022109117, Example 66)
Affinity DataIC50: 0.270nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559699(WO2022109117, Example 44)
Affinity DataIC50: 0.280nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559674(WO2022109117, Example 19)
Affinity DataIC50: 0.300nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559713(WO2022109117, Example 58)
Affinity DataIC50: 0.300nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559665(WO2022109117, Example 10)
Affinity DataIC50: 0.300nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559746(WO2022109117, Example 91)
Affinity DataIC50: 0.300nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559700(WO2022109117, Example 45)
Affinity DataIC50: 0.320nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559751(WO2022109117, Example 96)
Affinity DataIC50: 0.320nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559723(WO2022109117, Example 68)
Affinity DataIC50: 0.330nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559667(WO2022109117, Example 12)
Affinity DataIC50: 0.340nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559748(WO2022109117, Example 93)
Affinity DataIC50: 0.340nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559741(WO2022109117, Example 86)
Affinity DataIC50: 0.340nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559696(WO2022109117, Example 41)
Affinity DataIC50: 0.340nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559659(WO2022109117, Example 4)
Affinity DataIC50: 0.370nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559763(WO2022109117, Example 106)
Affinity DataIC50: 0.380nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559764(WO2022109117, Example 107)
Affinity DataIC50: 0.400nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559731(WO2022109117, Example 76)
Affinity DataIC50: 0.410nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559765(WO2022109117, Example 108)
Affinity DataIC50: 0.410nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559717(WO2022109117, Example 62)
Affinity DataIC50: 0.420nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559703(WO2022109117, Example 48)
Affinity DataIC50: 0.480nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

TargetOrexin receptor type 2(Human)
Merck Sharp &Amp

WIPO
LigandPNGBDBM559727(WO2022109117, Example 72)
Affinity DataIC50: 0.530nMAssay Description:In a typical experiment, the OXI and OX2 receptor agonist activity is determined in accordance with the following general experimental method. Chines...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109117

Displayed 1 to 50 (of 111 total ) | Next | Last >>
Jump to: